April 03, 2017
Israeli biotech company Enzymotec Ltd. and a putative class of shareholders have reached a $6.5 million settlement and asked a New Jersey federal judge on Friday to recognize the class and give the deal preliminary approval.
December 15, 2015
A New Jersey federal judge on Tuesday upheld most claims in a suit alleging Enzymotec Ltd. misrepresented its potential profitability ahead of an estimated $70 million initial public offering, saying shareholders provided sufficient evidence the Israeli biotechnology and health products company knew certain statements were false.
November 06, 2014
Shareholders suing Israeli biotechnology and health products company Enzymotec Ltd. for allegedly misrepresenting the company's potential profitability ahead of its estimated $70 million initial public offering last year asked a New Jersey federal court Wednesday to consolidate multiple cases.
September 09, 2014
Israeli biotechnology and health products company Enzymotec Ltd. was hit with a putative securities class action in New Jersey federal court Friday, alleging it defrauded investors by misrepresenting the company's potential profitability ahead of its estimated $70 million initial public offering last year.